Agena, HeartGenetics Ink Genetic Testing Comarketing Deal

Jul 18, 2017

|

NEW YORK (GenomeWeb) – Agena Bioscience announced today that it has signed an agreement to market its MassArray Dx system with HeartGenetics' HeartDecode genetic testing software and cardiovascular assays.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Agena, HeartGenetics Ink Genetic Testing Comarketing Deal

To read the full story....

Breaking News

Abbott POC Coronavirus Test Snares FDA Emergency Use Authorization

Luminex Receives FDA Emergency Use Authorization for Coronavirus Multiplex Panel

Gradientech Awarded $634K for Commercialization of AST Platform

UK Government Invests $28M in FIND to Support SARS-CoV-2 Test Development

Biolidics to Acquire Singapore Lab and Testing Business for up to S$3.7M

Sysmex Obtains Japan Marketing Approval to Distribute BGI Genomics Coronavirus Kit

Featured White Papers

What's Popular?

FDA Fleshes Out Emergency Guidance for Coronavirus Test Developers

BGI Americas Gets US Emergency Use Authorization for Coronavirus Test

Thermo Fisher Scientific COVID-19 Test Receives CE Mark, Expanded FDA EUA

BioMérieux Rapid Coronavirus Test Gets FDA Emergency Use Authorization

Luminex Receives FDA Emergency Use Authorization for Coronavirus Multiplex Panel

Sponsorships